|
|
Vaccine Detail
|
GX-19 |
| Vaccine Information |
- Vaccine Name: GX-19
- Target Pathogen: SARS-CoV-2
- Target Disease: COVID-19
- Manufacturer: Genexine
- Vaccine Ontology ID: VO_0005170
- Type: DNA vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Antigen: S protein (NCT04445389)
- Immunization Route: Intramuscular injection (i.m.)
- Description: A SARS-CoV-2 DNA vaccine expressing the SARS-CoV-2 S protein (NCT04445389)
|
| Host Response |
|
|
| References |
NCT04445389: Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults [https://clinicaltrials.gov/ct2/show/NCT04445389]
|
|
